MedPath

The effect of N-acetylcystein in outcome and adverse effects of intubation in neonates

Not Applicable
Conditions
Respiratoty Distress Syndrome of neonates.
Respiratory distress syndrome of newborn
Registration Number
IRCT138810012420N2
Lead Sponsor
Vice chancellor for research, Iran University of Medical Sciences and Health Services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
65
Inclusion Criteria

Inclusion Criteria: Neovates > 1200 gram hospitalized in NICU of Rasoul Akram hospital and needed to be intubated and mechanically ventilated based on standard protocols.

Exclusion Criteria

Neonates with major anomalies or cyanotic cardiac diseases, neonates who ere intubated at the beginning of their hospitalization, neonates with pneumothorax at the time of hospitalization or intubation, massive hemorrhage, neonates who were extubated before 24 hours or dead before this time

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The duration of first intubation until exchange of endotracheal tube due to mucus plug retention. Timepoint: every 6 hours. Method of measurement: Tube cleaning with drugs in order to make sure that it's open.
Secondary Outcome Measures
NameTimeMethod
umber of endotracheal tube obstruction and replacement due to mucus plug. Timepoint: every 6 hours. Method of measurement: cleaning of the endotracheak tube to make sure that it's open.;Duration of intubation. Timepoint: every day. Method of measurement: observation.;Events those may be related to the new drug including apnoea and bradycardia, hypotension, pulmonary haemorrhage. Timepoint: every 6 hours. Method of measurement: monitoring of the patient.;Death. Timepoint: every 6 hours. Method of measurement: control of vital signs.
© Copyright 2025. All Rights Reserved by MedPath